The enthusiasm of the entire Internet medical care is weakening, and the diabetes APP market, which was once in the air, has gradually calmed down from the excitement two years ago. After the melee of the "Hundred Sugar Battle", the pattern of the diabetes APP market has not yet been scheduled, but each platform has gradually gradually explored and tried to establish its own moat.
Since the beginning of this year, the distribution of Internet medical companies has become a trend. In the field of diabetes management, companies such as sugar doctors and micro-sugars have begun to deploy offline diabetes service centers. Of course, they have continued to adhere to the light asset model. Fujian Kangwei Technology Network Co., Ltd. (hereinafter referred to as "Kang Wei") is one of the control of diabetes app.
Different from other diabetes apps, controlling diabetes is not directly directed at C-terminal patients, but is to serve users by cooperating with tertiary hospitals and primary hospitals. Guo Xing, the founder of diabetes control, said that the current control of diabetes APP has covered 1,500 grassroots + tertiary hospitals.
"We want to be a partner in the hospital and the medical system, not their competitors, to help them manage diabetes in and out of the hospital," Guo said.
.jpg)
Since its inception in November 2013, one of the things that has been focused on diabetes has been to improve the effectiveness of diabetes management. It has also become a diabetes program in the Diabetes Mobile Medical Application Effectiveness Program initiated by the Chinese Center for Disease Control and Prevention (CDC). The exclusive partner of the management app.
The core of diabetes management is effectiveness
When the health point interviewed Guo Xin, he mentioned the most word "effectiveness." This is one of the most important indicators of whether the Diabetes Health Management APP is truly valuable.
The head of the CDC Mobile Medical Assessment Program said that the four indicators for evaluating the effectiveness of mobile medical applications are benchmarked, that is, “in line with the US FDA definition of MMA application, in line with the “Guidelines for the Prevention and Treatment of Type 2 Diabetes in Chinaâ€, with greater user experience and experience. Similar to Bluestar (the first doctor's prescription app in the US).
Conjugated linoleic acid (CLA) is one of the essential fatty acids for human and animals, but it is unable to synthesize a substance with significant pharmacological effect and nutritional value, which is of great benefit to human health. A large number of literatures have proved that conjugated linoleic acid has the physiological functions of anti-tumor, anti-oxidation, anti mutation, antibacterial, reducing human cholesterol, anti atherosclerosis, improving immunity, improving bone density, preventing diabetes and promoting growth. In recent years, some clinical studies have proved that conjugated linoleic acid can increase physical consumption after entering the body, so it can effectively reduce body fat deposition in weight control.
Product Name: Conjugated Linoleic Acid(CLA)
Appearance: White Crystalline Powder
Purity: 80%
Test Method: HPLC UV
Storage: Cool Dry Place
CAS: 121250-47-3
MF: C18H32O2
MW: 280.44
1.Increases metabolic rate
2.Decreases abdominal fat
3.Enhances muscle growth
4.Lowers cholesterol and triglycerides
5.Lowers insulin resistance
6.Reduces food-induced allergic reactions
7.Enhances immune system
1. Food and Beverage ingredients.
2. Healthy Products.
3. Nutrition Supplements.
Why choose us?
Product Recommended
Conjugated Linoleic Acid,Lysine Powder,Folic Acid,Vitamin D3
Xi'an Tian Guangyuan Biotech Co., Ltd. , https://www.tgybiotech.com